Sep 2026
Abstract B099: Tumor progression locus 2 kinase drives pancreatic cancer immune evasion through a MYBL2-CXCL10 signaling axis
Findings identify a previously unrecognized tumor-intrinsic TPL2-MYBL2-CXCL10 signaling axis that promotes immune evasion and targets TPL2-targeted therapies in PDAC, providing strong rationale for clinical development of TPL2-targeted therapies in PDAC.
Hua-Ping Li, Yu-Tong Geng, Hung-Han Huang et al.
· Cancer Research · 0 citations